Precision Neuroscience Corporation has successfully raised $102 million in Series C funding, aimed at advancing its brain-computer interface technology to transform treatments for neurological disorders. The funding, led by General Equity Holdings, will support clinical research and team expansion as the company develops a system designed to help paralyzed individuals control devices using their thoughts.

Harvard Medical School has secured a $6 million donation from the Dunleavy Foundation to enhance training in medical artificial intelligence. The funds will support various educational initiatives, including expanding the Medical AI Doctoral Program, aimed at preparing future healthcare professionals for an AI-integrated environment.